Issue Date | Title | Author(s) |
Jun-2013 | Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance | Camgöz, Aylin; Gençer, Emel Başak; Ural, Ali Uğur; Baran, Yusuf |
2015 | Mesenchymal stem cells administered intraperitoneally have a potent effects on the experimental allergic airway disease | Işık, S.; Adan, Aysun ; Karaman, M.; Kiray, M.; Bağrıyanık, H. A.; Çağlayan-Sözmen, S.; Uzuner, N.; Baran, Yusuf |
Aug-2011 | Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma | Fırıncı, Fatih; Karaman, Meral; Baran, Yusuf ; Bağrıyanık, Alper; Arıkan Ayyıldız, Zeynep; Kiray, Müge; Kozanoglu, İlknur; Yılmaz, Osman; Uzuner, Nevin; Karaman, Özkan |
2015 | The microarray gene profiling analysis of acute promyelocytic leukemia cells in response to fisetin and hesperetin | Adan Gökbulut, Aysun ; Baran, Yusuf |
2023 | MicroRNAs and long non-coding RNAs as novel targets in anti-cancer drug development | Çetinkaya, Melisa; Baran, Yusuf |
2018 | A minimally invasive transfer method of mesenchymal stem cells to the intact periodontal ligament of rat teeth: a preliminary study | Gül Amuk, Nisa; Kurt, Gökmen; Kartal Yandım, Melis; Adan, Aysun ; Baran, Yusuf |
Apr-2013 | miR-17 in imatinib resistance and response to tyrosine kinase inhibitors in chronic myeloid leukemia cells | Fıratlıgil, Burcu ; Biray Avcı, Çığır; Baran, Yusuf |
Feb-2016 | A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib | Kartal Yandım, Melis; Ceylan, Çağatay ; Elmas, Efe; Baran, Yusuf |
Jul-2016 | Molecular mechanisms of drug resistance and its reversal in cancer | Kartal Yandım, Melis; Adan Gökbulut, Aysun ; Baran, Yusuf |
Aug-2014 | Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer | Çinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
2014 | Multidrug resistance in chronic myeloid leukemia | Ünlü, Miray ; Kiraz, Yağmur ; Kacı, Fatma Necmiye; Özcan, Mehmet Ali; Baran, Yusuf |
Feb-2009 | Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients | Abaan, Ogan Demir; Mutlu, Pelin Kaya; Baran, Yusuf ; Atalay, Can; Gündüz, Ufuk |
2012 | A natural product, quercetin enhances the cytotoxic and apoptotic effects of dexamethasone on jurkat cells | Baran, Yusuf ; Kartal, Melis; Kozanoğlu, İlknur |
Feb-2013 | New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma | Kozanoğlu, İlknur; Kartal Yandım, Melis; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Çakmakoğlu, Bedia; Baran, Yusuf |
Oct-2015 | Nilotinib does not alter the secretory functions of carotid artery endothelial cells in a prothrombotic or antithrombotic fashion | Katgı, Abdullah; Sevindik, Ömer Gökmen; Adan Gökbulut, Aysun ; Özsan, Güner Hayri; Yüksel, Faize; Solmaz, Şerife Medeni; Alacacıoğlu, İnci; Özcan, Mehmet Ali; Demirkan, Fatih; Baran, Yusuf ; Pişkin, Özden |
Feb-2010 | Nilotinib significantly induces apoptosis in imatinib resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts | Ekiz, Hüseyin Atakan ; Can, Geylani; Gündüz, Ufuk; Baran, Yusuf |
2009 | Nilotinib significantly induces apoptosis in imatinib resistant K562 cells, as effectively as in parental sensitive counterparts | Baran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan |
2012 | A novel agent, KL-21, has significant anticancer potential on chronic lymphocytic leukemia cells but not on healthy cells | Baran, Yusuf ; Gökbulut, Aysun ; Yaşar, M. |
Jan-2013 | Novel agents targeting bioactive sphingolipids for the treatment of cancer | Adan Gökbulut, Aysun ; Kartal Yandım, Melis; İskender, Güniz; Baran, Yusuf |
2014 | A novel biomarker for drug resistance in chronic myeloid leukemia: MicroRNA-17 | Baran, Yusuf ; Fıratlıgil, Burcu ; Kartal Yandım, Melis; Kiraz, Yağmur ; Kozanoğlu, İlknur; Özdoğu, Hakan; Ünal, Ali |
Nov-2011 | A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes | Gencer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
2010 | A novel mechanism of nilotinib-induced apoptosis; bioactive sphingolipids | Baran, Yusuf ; Camgöz, Aylin; Gençer, Emel; Ural, Ali; Avcu, Ferit |
2015 | A novel natural product, KL-21, inhibits proliferation and induces apoptosis in chronic lymphocytic leukemia cells | Adan Gökbulut, Aysun ; Yaşar, Mustafa; Baran, Yusuf |
2008 | Optimization of transfection of green fluorescent protein in pursuing mesenchymal stem cells in vivo | Baran, Yusuf ; Ural, Ali Uğur; Avcu, Ferit; Sarper, Meral; Elçi, Pınar; Pekel, Aysel |
Apr-2022 | Peptıde targeted core cross-lınked mıcelles for dox delıvery to HER2 expressıng cancer cells | Bayram, Nazende Nur; Ulu, Gizem Tuğçe ; Gürdap, Seda; İşoğlu, İsmail Alper; Baran, Yusuf ; Dinçer İşoğlu, Sevil |
Nov-2015 | The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks | Adan, Aysun ; Baran, Yusuf |
2013 | Ponatinib regulates major signaling pathways in imatinib-resistant chronic myeloid leukemia cells | Avcı, Çığır Biray; Kayabaşı, Çağla; Yılmaz Süslüer, Sunde; Balcı, Tuğçe; Saydam, Güray; Baran, Yusuf ; Gündüz, Cumhur |
Apr-2010 | Proteasome inhibitor bortezomib increases radiation sensitivity in androgen independent human prostate cancer cells | Göktaş, Serdar; Baran, Yusuf ; Ural, Ali Uğur; Yazıcı, Sertaç; Aydur, Emin; Başal, Şeref; Avcu, Ferit; Pekel, Aysel; Dirican, Bahar; Beyzadeoğlu, Murat |
2012 | Quercetin induced apoptosis in 232B4 chronic lymphocytic leukemia cells | Baran, Yusuf ; Gökbulut, Aysun ; Apohan, Elif; Pişkin, Özden; Özcan, Mehmet Ali |
Sep-2011 | Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells | Avcı, Çığır Biray; Yılmaz, Sunde; Doğan, Zeynep Özlem; Saydam, Güray; Dodurga, Yavuz; Ekiz, Hüseyin Atakan ; Kartal, Melis; Şahin, Fahri; Baran, Yusuf ; Gündüz, Cumhur |
Jul-2007 | Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer | Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
2013 | Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest | Adan Gökbulut, Aysun ; Apohan, Elif; Baran, Yusuf |
May-2011 | Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells | Kartal Yandım, Melis; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
Sep-2015 | Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted “hsa-miR-2278” as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A | Tezcanlı Kaymaz, Burçin; Selvi Günel, Nur; Ceyhan, Metin; Bozok Çetintaş, Vildan; Özel, Buket; Kartal Yandım, Melis; Kıpçak, Sezgi; Aktan, Çağdaş; Adan Gökbulut, Aysun ; Baran, Yusuf ; Kosova Can, Buket |
Mar-2012 | Role of autophagy in the progression and suppression of leukemias | Ekiz, Hüseyin Atakan ; Can, Geylani; Baran, Yusuf |
2022 | The role of miRNA in cancer: Pathogenesis, diagnosis, and treatment | Uzuner, Erez; Ulu, Gizem Tuğçe ; Gürler, Sevim Beyza; Baran, Yusuf |
Oct-2011 | The roles of antiapoptotic sphingosine kinase-1 and glucosylceramide genes in drug induced cell death of MCF-7 breast cancer cells | Güçlüler, Gözde; Pişkin, Özden; Baran, Yusuf |
Feb-2011 | The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cells | Çakır, Zeynep; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
2010 | The roles of ceramide metabolizing gennes on resveratrol induced apoptosis in human hl60 acute myeloid leukemia cells | Çakır, Zeynep |
Aug-2011 | Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloidleukemia cells | Camgöz, Aylin; Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
Jul-2013 | The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinibresistant chronic myeloid leukemia cells | Bozkurt, Süreyya; Özkan, Tülin; Özmen, Füsun; Baran, Yusuf ; Sunguroglu, Asuman; Kansu, Emin |
Apr-2013 | The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopy | Baran, Yusuf ; Ceylan, Çağatay ; Camgöz, Aylin |
2010 | The roles of STAT transcription Factors in imatinib resistance and sensitivity in BCR/ABL positive chronic myeloid leukemia cells | Baran, Yusuf ; Kosova, Buket; Tezcanlı, Burçin; Ekiz, Hüseyin Atakan ; Çakır, Zeynep; Selvi, Nur |
Nov-2019 | Sensitization of Philadelphia positive acute lymphoblastic leukemia cells resistant to imatinib by targeting sphingolipid metabolism | Kiraz, Yağmur |
Jun-2011 | Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A | Salas, Arelis; Ponnusamy, Suriyan; Senkal, Can E.; Meyers-Needham, Marisa; Selvam, Shanmugam Panneer; Saddoughi, Sahar A.; Apohan, Elif; Sentelle, R. David; Smith, Charles; Gault, Christopher R.; Obeid, Lina M.; El-Shewy, Hesham M.; Oaks, Joshua; Santhanam, Ramasamy; Marcucci, Guido; Baran, Yusuf ; Mahajan, Sandeep; Fernandes, Daniel; Stuart, Robert; Perrotti, Danilo; Öğretmen, Besim |
2015 | Sphingosine-1-phosphate receptor 2/GQ/Phospholıpase C Axis is a novel mechanism to overcome nilotinib resistance in T315I mutation expressing 32DCL3 murine cells | Adan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf |
Jul-2013 | STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells | Kiper, Hatice Demet; Tezcanlı Kaymaz, Burçin; Adan Gökbulut, Aysun ; Selvi, Nur; Biray Avcı, Çığır; Kosova, Buket; İskender, Güniz; Kartal Yandım, Melis; Gündüz, Cumhur; Şahin, Fahri; Baran, Yusuf ; Saydam, Güray |
2007 | A study of multiple drug resistance mechanisms improved against Bortezomib on multiple myeloma cell lines in vitro | Uyuklu, Tolga; Ural, A. Uğur; Sarper, Metal; Avcu, Ferit; Baran, Yusuf ; Elçi, Pınar; Akar, Nejat |
2014 | Suppression of STAT5A and STAT5B chronic myeloid leukemia cells via siRNA and antisense-oligonucleotide applications with the induction of apoptosis | Tezcanlı Kaymaz, Burçin; Selvi, Nur; Adan Gökbulut, Aysun ; Aktan, Çağdaş; Gündüz, Cumhur; Saydam, Güray; Baran, Yusuf ; Kosova, Buket |
Oct-2010 | Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells | Kosova, Buket; Tezcanlı, Burçin; Ekiz, Hüseyin Atakan ; Çakır, Zeynep; Selvi, Nur; Dalmızrak, Ayşegül; Yandım, Melis Kartal; Gündüz, Ufuk; Baran, Yusuf |
2015 | Synergistic apoptotic effects of bortezomib and methylstat inhibitor on different multiple myeloma cell lines | Kacı, Fatma Necmiye |
2015 | Synergistic apoptotic effects of bortezomib and methylstat on different multiple myeloma cell lines | Kacı, Necmiye; Kiraz, Yağmur ; Baran, Yusuf |
2020 | Synergistic apoptotic effects of bortezomib and methylstat on multiple myeloma cells | Kaci, Fatma Necmiye; Kiraz, Yağmur ; Çekdemir, Demet; Baran, Yusuf |
Jan-2017 | Synthesis, cytotoxic and antimicrobial activities of novel cobalt and zinc complexes of benzimidazole derivatives | Apohan, Elif; Yılmaz, Ülkü; Yılmaz, Özgür; Serindağ, Ayfer; Küçükbay, Hasan; Yeşilada, Özfer; Baran, Yusuf |
Jan-2016 | T cells in tumor microenvironment | Kiraz, Yağmur ; Baran, Yusuf ; Nalbant, Ayten |
2009 | Targeting ceramide metabolism increased sensitivity of Philadelphia positif chronic megacaryoblastic leukemia cells to dasatinib | Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
Mar-2015 | Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line | Tüfekçi, Özlem; Kartal Yandım, Melis; Ören, Hale; İrken, Gülersu; Baran, Yusuf |
Oct-2011 | Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation | Baran, Yusuf ; Bielawski, Jacek; Gündüz, Ufuk; Öğretmen, Besim |
2014 | Targeting sphingosine kinase-1/spingosine-1-phosphate receptor 2 signalling pathway to overcome T315I mutation in 32DCL3 cells | Adan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf |
Oct-2010 | Therapeutic applications of bioactive sphingolipids in hematological malignancies | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
May-2014 | Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells | Solmaz, Soner; Adan Gökbulut, Aysun ; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Boğa, Can; Çakmakoğlu, Bedia; Kozanoğlu, İlknur; Baran, Yusuf |
2015 | Therapeutic potential of fisetin and identification of its mechanisms in action in chronic myeloid leukemia and acute promyelocytic leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
2014 | Therapeutic potential of fisetin, vitexin and hesperetin on chronic myeloid leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
2023 | Therapeutic potential of luteolin on cancer | Çetinkaya, Melisa; Baran, Yusuf |
Jan-2013 | Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer | Kartal Yandım, Melis; Apohan, Elif; Baran, Yusuf |
2010 | Therapeutic potential of targeting sphingolipid signaling pathways in various types of cancers | Baran, Yusuf ; Başsoy, Esen Yonca; Çakır, Zeynep; Camgöz, Aylin; Gencer, Emel Başak; Kartal, Melis; Can, Geylani; Ekiz, Hüseyin Atakan ; Güçlüler, Gözde |
2015 | Therapeutic potentials of fisetin, hesperetin and vitexin on chronic myeloid leukemia and acute myeloid leukemia cells | Adan Gökbulut, Aysun |
2020 | Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia | Koca, Duygu; Hastar, Nurcan; Engür, Selin; Kiraz, Yağmur ; Ulu, Gizem Tuğçe ; Çekdemir, Demet; Baran, Yusuf |
Dec-2015 | An update on molecular biology and drug resistance mechanisms of multiple myeloma | Mutlu, Pelin; Kiraz, Yağmur ; Gündüz, Ufuk; Baran, Yusuf |
Jan-2014 | An update on molecular biology of thyroid cancers | Ömür, Özgür; Baran, Yusuf |
Dec-2007 | Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance | Baran, Yusuf ; Gür, Bala; Kaya, Pelin; Ural, Ali Uğur; Avcu, Ferit; Gündüz, Ufuk |
2014 | Use of microRNAs in personalized medicine | Avcı, Çığır Biray; Baran, Yusuf |
2024 | X. Eğitim çalıştayı raporu | Tanoğlu, Gamze ; Özcan Gönülal, Yasemin ; Baran, Yusuf ; Yürüm, Ozan Raşit; Örün, Özgür; Daver, İlker; Gündüz, Umut Baran |
2012 | Zoledronate induces apoptosis via effecting on stat pathway in chronic myeloid leukemia cells | Saydam, Güray; Kiper, Hatice Demet; Tezcanlı, Burçin; Selvi, Nur; Avcı, Çığır Biray; Baran, Yusuf ; Şahin, Fahri |